MTOR and hepatocellular carcinoma: Zhou et al. have shown the potential role of mTOR signaling in breast cancer stem cells that increased the clonogenic ability and tumor formation in vitro and xenograft models, respectively.131 Treatment of HCC with branched-chain amino acids resulted in the activation of mTORC1.